RU2002125493A - Эндопаразитицидные средства - Google Patents

Эндопаразитицидные средства

Info

Publication number
RU2002125493A
RU2002125493A RU2002125493/15A RU2002125493A RU2002125493A RU 2002125493 A RU2002125493 A RU 2002125493A RU 2002125493/15 A RU2002125493/15 A RU 2002125493/15A RU 2002125493 A RU2002125493 A RU 2002125493A RU 2002125493 A RU2002125493 A RU 2002125493A
Authority
RU
Russia
Prior art keywords
contain
funds
endoparasiticid
agents
lidenglycerin
Prior art date
Application number
RU2002125493/15A
Other languages
English (en)
Other versions
RU2292905C2 (ru
Inventor
Йохен КАЛЬБЕ (DE)
Йохен Кальбе
Михаэль ТРОЙБЕЛЬ (DE)
Михаэль Тройбель
ЗАМЗОН-ХИММЕЛЬШТЬЕРНА Георг ФОН (DE)
ЗАМЗОН-ХИММЕЛЬШТЬЕРНА Георг ФОН
Ахим ХАРДЕР (DE)
Ахим ХАРДЕР
Михаэль ШТЕГЕМАНН (DE)
Михаэль ШТЕГЕМАНН
Норберт МЕНКЕ (DE)
Норберт МЕНКЕ
Original Assignee
Байер Акциенгезелльшафт (De)
Байер Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Акциенгезелльшафт (De), Байер Акциенгезелльшафт filed Critical Байер Акциенгезелльшафт (De)
Publication of RU2002125493A publication Critical patent/RU2002125493A/ru
Application granted granted Critical
Publication of RU2292905C2 publication Critical patent/RU2292905C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Claims (6)

1. Средства, содержащие циклические депсипептиды как таковые или в смеси с другими активными началами, отличающиеся тем, что они содержат растворитель или смесь растворителей, и тем, что эти средства годятся для местного применения у животных.
2. Средства по п.1, отличающиеся тем, что они содержат 1,2-изопропи-лиденглицерин.
3. Средства по п.1, отличающиеся тем, что они содержат 1,2-изопропи-лиденглицерин и бензиловый спирт и/или диацетат пропиленгликоля.
4. Средства по п.1, отличающиеся тем, что они содержат бензиловый спирт и/или диацетат пропиленгликоля.
5. Способ получения средств по пп.1-4, отличающиеся тем, что активные начала смешивают с растворителями и, при необходимости, дальнейшими вспомогательными веществами.
6. Применение средств по пп.1-4 для борьбы с эндопаразитами.
RU2002125493/15A 2000-02-22 2001-02-09 Эндопаразитицидные средства RU2292905C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
DE10008128.2 2000-02-22

Publications (2)

Publication Number Publication Date
RU2002125493A true RU2002125493A (ru) 2004-03-20
RU2292905C2 RU2292905C2 (ru) 2007-02-10

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002125493/15A RU2292905C2 (ru) 2000-02-22 2001-02-09 Эндопаразитицидные средства

Country Status (25)

Country Link
US (1) US20030125244A1 (ru)
EP (1) EP1259250B1 (ru)
JP (2) JP5596249B2 (ru)
KR (1) KR100755414B1 (ru)
CN (1) CN1309415C (ru)
AR (2) AR028218A1 (ru)
AT (1) ATE343394T1 (ru)
AU (2) AU2001240605B2 (ru)
BR (1) BR0108562B1 (ru)
CA (1) CA2400610C (ru)
CZ (1) CZ300242B6 (ru)
DE (2) DE10008128A1 (ru)
DK (1) DK1259250T3 (ru)
ES (1) ES2274871T3 (ru)
HK (1) HK1054326B (ru)
HU (1) HUP0204554A3 (ru)
IL (2) IL150988A0 (ru)
MX (1) MXPA02008210A (ru)
NO (1) NO328949B1 (ru)
NZ (1) NZ520856A (ru)
PL (1) PL203999B1 (ru)
PT (1) PT1259250E (ru)
RU (1) RU2292905C2 (ru)
WO (1) WO2001062268A1 (ru)
ZA (1) ZA200205982B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
BR0215937A (pt) * 2002-11-12 2005-09-06 Kitasato Inst Substância fki-1033, processo para sua produção, seu uso, microorganismo consistindo em verticillium sp fki-1033, agente inibidor de ligação de rianodina, agente inseticida e anti-helmìntico, e agente inibidor de ligação de rianodina, inseticida e anti-helmìntico
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AP2728A (en) 2008-08-28 2013-08-31 Pfizer Dioxa-bicyclo[3.2.1.] octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
SG10202103403SA (en) 2015-05-20 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
CN108699052B (zh) 2015-12-28 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN114698369A (zh) 2019-08-14 2022-07-01 威隆股份公司 用于防治寄生虫的包含替戈拉纳的组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
ATE211466T1 (de) * 1992-03-17 2002-01-15 Fujisawa Pharmaceutical Co Depsipeptide, herstellung und anwendung
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (fr) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha Preparation sous forme de solution a base d'une forte concentration d'aureobasidine
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO1999047139A1 (en) * 1998-03-19 1999-09-23 Merck & Co., Inc. Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
US20030125244A1 (en) 2003-07-03
NO328949B1 (no) 2010-06-28
HK1054326A1 (en) 2003-11-28
NO20023976D0 (no) 2002-08-21
CZ300242B6 (cs) 2009-03-25
MXPA02008210A (es) 2003-01-28
RU2292905C2 (ru) 2007-02-10
PL203999B1 (pl) 2009-11-30
AU2001240605B2 (en) 2005-04-21
AR085989A2 (es) 2013-11-13
DE50111315D1 (de) 2006-12-07
BR0108562A (pt) 2002-11-12
EP1259250A1 (de) 2002-11-27
WO2001062268A1 (de) 2001-08-30
DE10008128A1 (de) 2001-08-23
CN1309415C (zh) 2007-04-11
ES2274871T3 (es) 2007-06-01
BR0108562B1 (pt) 2013-03-05
IL150988A0 (en) 2003-02-12
AR028218A1 (es) 2003-04-30
NZ520856A (en) 2005-04-29
CZ20022867A3 (cs) 2003-01-15
HUP0204554A3 (en) 2005-05-30
ZA200205982B (en) 2003-07-28
JP2003523397A (ja) 2003-08-05
CN1404397A (zh) 2003-03-19
EP1259250B1 (de) 2006-10-25
AU4060501A (en) 2001-09-03
NO20023976L (no) 2002-10-21
JP2012107024A (ja) 2012-06-07
PT1259250E (pt) 2007-01-31
CA2400610C (en) 2013-01-22
HK1054326B (zh) 2007-11-09
ATE343394T1 (de) 2006-11-15
KR100755414B1 (ko) 2007-09-04
JP5596249B2 (ja) 2014-09-24
PL357551A1 (en) 2004-07-26
KR20020072577A (ko) 2002-09-16
CA2400610A1 (en) 2001-08-30
DK1259250T3 (da) 2007-02-26
HUP0204554A2 (en) 2003-05-28
IL150988A (en) 2011-06-30

Similar Documents

Publication Publication Date Title
AR012673A1 (es) Compuesto de ester de etilenglicol de monohidrobenzoporfirina utiles para terapia fotodinamica, composiciones farmaceuticas y uso de los mismos.
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
ITRM920381A0 (it) Composizione farmaceutica per applicazione topica, quale smalto per unghie.
BR0002638A (pt) Composições de zinco tópicas e processo de uso
DE60118917D1 (de) PYRROLOi2,3-DöPYRIMIDIN VERBINDUNGEN ALS IMMUNOSUPPRESSIVE WIRKSTOFFE
CR7614A (es) Preparaciones de insulina acida con estabilidad mejorada
BRPI0409133B8 (pt) preparações farmacêuticas estavéis compreendendo metilnaltrexona
RU93033479A (ru) Способ получения замещенных пирролов, способ получения фармацевтических препаратов
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
RU2002125493A (ru) Эндопаразитицидные средства
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
ES2004395A6 (es) Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos.
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
IT1320764B1 (it) Uso di composti (per)fluoropolieterei come additivi in formulazioni.
IT1239789B (it) Componente semiconduttore di potenza, cellulare.
ITBO960197A0 (it) Elettrocatetere, in particolare per uso temporaneo
DE3863830D1 (de) Arzneimittelformulierung.
BR0116762A (pt) Análogos tacrolimus neurotróficos, métodos e uso dos mesmos
SE9902742D0 (sv) New pharmaceutical formultion
RU2002135455A (ru) Гептапептид последовательности met-glu-his-phe-pro-gly-pro с нейропротекторной активностью и фармацевтическая композиция на его основе
DE69007651D1 (de) 5-Carbamoylthieno(2,3-B)thiophen-2-sulfonamide als topisch aktive Kohlensäureanhydraseinhibitoren.
NL7711777A (nl) Biologisch actieve tricyclische verbindingen en farmaceutische samenstellingen, welke deze verbindingen als actief bestanddeel bevatten.

Legal Events

Date Code Title Description
PC4A Invention patent assignment

Effective date: 20070411

ND4A Extension of patent duration
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20101005

PC41 Official registration of the transfer of exclusive right

Effective date: 20101129

PC41 Official registration of the transfer of exclusive right

Effective date: 20130207

MM4A The patent is invalid due to non-payment of fees

Effective date: 20210210